Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
This podcast looks at three men. First is the criminal fraudster and expenses thief Rob Terry and I discuss what sort of trial and what sort of punishment needs to take place and be imposed. Then it is fund manager Neil Woodford and I look at his growing biotech headaches. Finally the greedy pig Richard Chase of Nyota. If you have not yet listened to yesterday's special on this failure of a CEO please do so and send the email I request.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments
Scampi
Re raising money on a false prospectus – 1 glaring example is Len Fertig of Motive Television (MTV).
He raised around £600,000 if I remember correctly telling investors it was to be used to settle litigation in Spain – he made out that it was an agreed settlement only to casually mention MONTHS later in an RNS that the dispute was still ongoing!
I’d love to see the toerag prosecuted for that! Slam dunk IMO!
David Williams
I have also wondered about Woodford and his multiple biotech investments. Is he playing the odds in that a successful early stage biotech company will see its share price increase by multiples? Hence he can afford a few losers? However Northwestern does appear to be just a bad investment. And the fact that he is invested does seem to be taken by some investors as a guarantee of success.